William Grossman, Chief Medical Officer at Arcus Biosciences, Inc. (RCUS), bought 200 shares at $19.68 ($4K) on 2020-07-31, disclosed to the SEC on 2020-08-04.
Open-market purchase of $4k RCUS by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.68 | 100 | $2K | 49.9% |
| 2 | $19.77 | 100 | $2K | 50.1% |
| Total | $19.73 avg | 200 | $4K | 100% |
| Filing → |
| RCUS | SELL | 2021-04-26 | $259K | — | Filing → |
| RCUS | SELL | 2021-03-18 | $149K | — | Filing → |
| RCUS | SELL | 2020-12-18 | $133K | — | Filing → |